ADC Therapeutics SA (ADCT)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 01:52PM EDT. Market open.
| Previous Close | 4.4500 |
| Open | 4.4000 |
| Bid | 4.7700 x 800 |
| Ask | 4.8000 x 800 |
| Day's Range | 4.3397 - 4.8000 |
| 52 Week Range | 0.3600 - 6.0400 |
| Volume | |
| Avg. Volume | 636,227 |
| Market Cap | 396.679M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript
ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript May 6, 2024 ADC Therapeutics SA reports earnings inline with expectations. Reported EPS is $-0.56 EPS, expectations were $-0.56. ADCT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and […]
- Zacks
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of 0% and 0.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results
There's been a notable change in appetite for ADC Therapeutics SA ( NYSE:ADCT ) shares in the week since its annual...
© 2024 Yahoo. All rights reserved.